去年，Transmedics Group Inc表现最佳的业务板块OCS Liver net revenue实现营收460.53M美元。United States的营收贡献最高，去年达到584.70M美元。最近一个季度，截至2026-06-30，Transmedics Group Inc表现最佳的业务板块OCS Liver net revenue实现营收148.23M美元。United States的营收贡献最高，达到183.62M美元。

业务

营业收入

占比

年报

年报

单季报

OCS Liver net revenue

OCS Heart net revenue

OCS Lung net revenue

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

OCS Liver net revenue

460.53M(76.58%)

309.62M(70.83%)

151.82M(64.13%)

46.26M(49.50%)

1.91M(6.32%)

5.25M(20.47%)

3.50M(14.82%)

OCS Heart net revenue

126.01M(20.95%)

109.86M(25.13%)

73.09M(30.88%)

38.35M(41.04%)

17.68M(58.43%)

14.20M(55.37%)

11.44M(48.47%)

OCS Lung net revenue

14.86M(2.47%)

17.68M(4.04%)

11.82M(4.99%)

8.85M(9.47%)

10.66M(35.24%)

6.19M(24.16%)

8.66M(36.71%)

地区

营业收入

占比

年报

年报

单季报

United States

All other countries

United Kingdom

Germany

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

United States

584.70M(97.22%)

421.88M(96.50%)

221.35M(93.50%)

84.04M(89.92%)

21.86M(72.24%)

19.24M(75.04%)

16.25M(68.86%)

6.54M(50.27%)

2.74M(35.71%)

3.47M(55.85%)

All other countries

16.70M(2.78%)

15.28M(3.50%)

15.39M(6.50%)

9.42M(10.08%)

8.40M(27.76%)

6.40M(24.96%)

3.97M(16.82%)

2.44M(18.73%)

2.59M(33.66%)

1.39M(22.37%)

United Kingdom

--(--)

2.23M(9.46%)

2.58M(19.82%)

2.35M(30.63%)

1.35M(21.77%)

Germany

--(--)

1.15M(4.86%)

1.46M(11.19%)

--(--)